Cargando…

Beta‐blockers for hypertension

BACKGROUND: Beta‐blockers refer to a mixed group of drugs with diverse pharmacodynamic and pharmacokinetic properties. They have shown long‐term beneficial effects on mortality and cardiovascular disease (CVD) when used in people with heart failure or acute myocardial infarction. Beta‐blockers were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiysonge, Charles S, Bradley, Hazel A, Volmink, Jimmy, Mayosi, Bongani M, Opie, Lionel H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2017
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369873/ https://www.ncbi.nlm.nih.gov/pubmed/28107561 http://dx.doi.org/10.1002/14651858.CD002003.pub5

Ejemplares similares

Cochrane corner: beta-blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2018)

Beta-blockers and the treatment of hypertension: it is time to move on
por: Wiysonge, Charles Shey, et al.
Publicado: (2007)

HIV Infection Is Associated with a Lower Incidence of Constriction in Presumed Tuberculous Pericarditis: A Prospective Observational Study
por: Ntsekhe, Mpiko, et al.
Publicado: (2008)

Interventions for treating tuberculous pericarditis
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
por: Robertson, Katharine A, et al.
Publicado: (2005)

The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature
por: Ntsekhe, Mpiko, et al.
Publicado: (2012)

Developing the African national health research systems barometer
por: Kirigia, Joses Muthuri, et al.
Publicado: (2016)

The efficacy and safety of complete pericardial drainage by means of intrapericardial fibrinolysis for the prevention of complications of pericardial effusion: a systematic review protocol
por: Kakia, Aloysious, et al.
Publicado: (2016)

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
por: Tomiyama, Hirofumi, et al.
Publicado: (2014)

The current status of beta blockers’ use in the management of hypertension
por: Akbar, Shahid, et al.
Publicado: (2014)

Hypertension, the changing pattern of drug usage
por: Lionel H, Opie
Publicado: (2009)

Incentives and enablers to improve adherence in tuberculosis
por: Lutge, Elizabeth E, et al.
Publicado: (2015)

The Changing Landscape of Hypertension and the Evolving Role of Vasodilatory Beta-Blockers
por: Bakris, George L., et al.
Publicado: (2007)

Increasing the value of health research in the WHO African Region beyond 2015—reflecting on the past, celebrating the present and building the future: a bibliometric analysis
por: Uthman, Olalekan A, et al.
Publicado: (2015)

Cardiomyopathies and myocardial disorders in Africa: present status and the way forward
por: Mayosi, Bongani M
Publicado: (2013)

Beta‐Blocker Use Is Associated With Impaired Left Atrial Function in Hypertension
por: Sardana, Mayank, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy
por: Ntusi, Ntobeko B. A., et al.
Publicado: (2015)

Genomic medicine in Africa: promise, problems and prospects
por: Wonkam, Ambroise, et al.
Publicado: (2014)

Cardiomyopathy in Africa: heredity versus environment
por: Mayosi, Bongani M, et al.
Publicado: (2007)

The Pan-African Society of Cardiology (PASCAR) in 2013 and beyond
por: Dzudie, Anastase, et al.
Publicado: (2013)

Impact of Molecular Genetics on Clinical Cardiology
por: Mayosi, Bongani M, et al.
Publicado: (1999)

Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
por: de Roquetaillade, Charles, et al.
Publicado: (2022)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

the contribution of south Africans to the subject of dilated cardiomyopathy
por: Watkins, David A, et al.
Publicado: (2009)

Exploring Sex Differences of Beta-Blockers in the Treatment of Hypertension: A Systematic Review and Meta-Analysis
por: Wilmes, Nick, et al.
Publicado: (2023)

Mechanism and Effect of Beta-Blockers on Pancreatic Adenocarcinoma: A Literature Review
por: Upadhyaya, Vandan D., et al.
Publicado: (2020)

Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence
por: Alsagaff, Mochamad Yusuf, et al.
Publicado: (2021)

A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa: reply to Bovet et al., and Gao et al.
por: Kengne, Andre Pascal, et al.
Publicado: (2012)

A snapshot of cardiovascular diseases in Africa in the new millennium
por: Kengne, Andre Pascal, et al.
Publicado: (2013)

Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
por: Patel, Rachna S., et al.
Publicado: (2014)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

Beta-Blockers in the Critically Ill: Friend or Foe?
por: Senussi, Mourad H.
Publicado: (2021)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
por: Östman-Smith, Ingegerd
Publicado: (2014)

Beta-Blockers and Cancer: Where Are We?
por: Peixoto, Rita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pdrfg6a7mhondc9d5anijmdrt8